Haemonetics | HAE - Ebitda

Stock Price
56.29
Daily Change
-0.83 -1.45%
Monthly
-6.36%
Yearly
-19.94%
Q2 Forecast
53.98

Haemonetics reported $94.78M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Avanos Medical USD 13M 3M Dec/2025
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Fresenius EUR 951M 283M Mar/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 94.78M 20.75M Dec/2025
ICU Medical USD 98.68M 489K Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
Masimo USD 85.5M 6.4M Mar/2026
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Neogen USD 48.2M 546K Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Quidel USD 108.7M 44.6M Mar/2026
ResMed USD 547.48M 27.46M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Steris USD 394.7M 5M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Surmodics USD 3.43M 1.9M Jun/2025
Teleflex USD 247.07M 575.88M Dec/2025
Terumo JPY 57.88B 12.1B Mar/2026
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
US Physical Therapy USD 24.75M 899K Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025